← All trials
NCT00537810
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2007
- Primary completion
- Oct 1, 2012
- Completion date
- Oct 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 104
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Yale UniversityLead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- Yale UniversityOverall official - principal investigator
- Yale UniversityReponsible party - principal investigator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.